Date Posted – 11 June 2021
An exceptional leadership opportunity in cutting-edge biotech
Gertrude Biomedical is a Melbourne-based company dedicated to developing novel small molecules to treat serious disease by blocking pathological vascular growth.
You will work together with the CEO/ CSO and other Management and Science Team members to drive business critical activities and projects. This carries responsibility for the initiation, planning, execution, monitoring and completion of the medicinal chemistry program, from hit-to-lead identification through to IND studies.
In addition to superior postgraduate credentials, you are experienced in pre-clinical and/or clinical small molecule inhibitor development. Further, you have led and motivated teams, demonstrating the capacity to communicate effectively with investigators, regulators, funding bodies and investors.
Please view the Position Details on www.brookerconsulting.com.au and send a brief resume by 5pm AEST Monday July 5 to email@example.com, or ring Jeremy Wurm on 0419529525 or Lesley Lightfoot on 0458543485, in confidence.